28 completed, 6 recruiting, 6 unknown, 3 terminated. 46 Phase 2, 14 Phase 1, 7 Phase 3.
Follow Cardiomyopathy, Dilated: new trials by email Literature Review of Cardiomyopathy, Dilated trials Research Report on Cardiomyopathy, Dilated
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM) AFTX-201 - Dilated Cardiomyopathy (DCM), BAG3 Mutation Associated Dilated Cardiomyopathy | Phase 1 / Phase 2 | Recruiting | Affinia Therapeutics | 22 | 2026-12-01 | 2026-11-03 |
| A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA) NVC-001 - Low Dose, NVC-001 - Intermediate Dose, NVC-001 - High Dose - LMNA-Related Dilated Cardiomyopathy | Phase 1 / Phase 2 | Recruiting | Nuevocor Pte. Ltd. | 21 | 2026-06-16 | 2026-08-07 |
| Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study) HS-005 - Heart Failure, Ischemic Heart Failure | Phase 1 / Phase 2 | Recruiting | Heartseed Inc. | 14 | 2026-01-19 | 2026-10-22 |
| the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients Empagliflozin (EMPA), Standard medical treatment - Heart Failure | Phase 2 | Recruiting | Ain Shams University | 60 | 2025-12-01 | 2026-07-09 |
| Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure | Phase 1 / Phase 2 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 43 | 2025-04-22 | 2026-07-14 |
| Examining the Effects of Mitochondrial Oxidative Stress in DCM MitoQ Compound, Placebo - Dilated Cardiomyopathy | Phase 2 | Completed | Imperial College London | 53 | 2022-07-26 | 2025-09-18 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Ifetroban, Placebo - Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated | Phase 2 | Completed | Cumberland Pharmaceuticals | 46 | 2020-10-19 | 2026-03-17 |
| Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation simvastatin therapy - Dilated Cardiomyopathy | Phase 2 | Recruiting | National Taiwan University Hospital | 230 | 2020-08-15 | 2024-10-16 |
| Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities danicamtiv - Primary Familial Dilated Cardiomyopathy | Phase 2 | Terminated | Bristol-Myers Squibb | 41 | 2020-08-04 | 2025-05-21 |
| Early Administration of Ivabradine in Children With Heart Failure Ivabradine 5Mg Tab - Acute Heart Failure, Dilated Cardiomyopathy | Phase 2 | Unknown | Bambino Gesù Hospital and Research Institute | 9 | 2020-06-20 | 2020-12-08 |
| The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor BC 007 - Cardiomyopathy, Dilated, Heart Failure | Phase 2 | Completed | Berlin Cures GmbH | 30 | 2019-03-29 | 2023-04-03 |
| Simvastatin Therapy in Patients With Dilated Cardiomyopathy. Simvastatin - Dilated Cardiomyopathy | Phase 2 | Completed | National Taiwan University Hospital | 8 | 2019-01-17 | 2022-08-03 |
| Bisoprolol in DMD Early Cardiomyopathy Bisoprolol Fumarate - Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 42 | 2019-01-16 | 2022-09-28 |
| Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM Bone marrow derived mononuclear cells and G-CSF - Dilated Cardiomyopathy | Phase 2 | Active not recruiting | Barts & The London NHS Trust | 20 | 2018-12-24 | 2026-04-06 |
| v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491 MYK-491, Placebo - Heart Failure With Reduced Ejection Fraction, Dilated Cardiomyopathy | Phase 1 / Phase 2 | Completed | Bristol-Myers Squibb | 52 | 2018-02-06 | 2023-02-02 |
| Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study Left Cardiac Sympathetic Denervation (LCSD), Optimal Medical Therapy - Dilated Cardiomyopathy, Ischemic Cardiomyopathy | Phase 2 | Suspended | University of Cape Town | 30 | 2016-11-24 | 2021-05-06 |
| Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril Enalapril Orodispersible Minitablet - Heart Failure, Dilated Cardiomyopathy | Phase 2 / Phase 3 | Unknown | Ethicare GmbH | 100 | 2016-03-01 | 2016-01-13 |
| Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy Enalapril Orodispersible Minitablet - Heart Failure, Dilated Cardiomyopathy | Phase 2 / Phase 3 | Unknown | Ethicare GmbH | 50 | 2016-01-01 | 2016-01-12 |
| Honey in Idiopathic Dilated Cardiomyopathy honey - Idiopathic Dilated Cardiomyopathy | Phase 2 / Phase 3 | Completed | mamdouh abdulmaksoud abdulrhman | 50 | 2015-11-01 | 2016-12-12 |
| A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy ARRY-371797, p38 inhibitor, oral - LMNA-Related Dilated Cardiomyopathy | Phase 2 | Completed | Pfizer | 8 | 2015-02-02 | 2022-03-31 |
Showing 20 of 46. Sign in to see all of them.
Heart Failure (24) · Cardiomyopathies (7) · Coronary Disease (2) · Laminopathies (2) · Campomelic Dysplasia (1) · Cardiovascular Diseases (1) · Distal Myopathies (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Muscular Dystrophy, Duchenne (1) · Myocardial Ischemia (1) · familial dilated cardiomyopathy (1)
Cardiomegaly (46) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (46) · Genetic Diseases, Inborn (46) · Cardiovascular Diseases (45) · Heart Diseases (45) · Laminopathies (44) · Cardiomyopathies (39) · Vascular Diseases (3) · Congenital Abnormalities (2) · Muscular Diseases (2) · Muscular Disorders, Atrophic (2) · Muscular Dystrophies (2) · Musculoskeletal Diseases (2) · Myocardial Ischemia (2) · Nervous System Diseases (2)
ARRY-371797 (2) · Granulocyte Colony-Stimulating Factor (2) · Standard of Care (2) · Allopurinol (1) · Bisoprolol (1) · Cardiac Resynchronization Therapy (1) · Dobutamine (1) · Drug Therapy (1) · Honey (1) · Ivabradine (1) · Lenograstim (1) · Perhexiline (1) · Positron-Emission Tomography (1) · Ranolazine (1) · Simvastatin (1)
University Medical Centre Ljubljana (4) · Barts & The London NHS Trust (2) · Bristol-Myers Squibb (2) · Ethicare GmbH (2) · Instituto de Cardiologia do Rio Grande do Sul (2) · LoneStar Heart, Inc. (2) · National Taiwan University Hospital (2) · Pfizer (2) · Vericel Corporation (2) · Affinia Therapeutics (1) · Ain Shams University (1) · Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1) · Bambino Gesù Hospital and Research Institute (1) · Berlin Cures GmbH (1) · Celladon Corporation (1)
United States (14) · United Kingdom (8) · Germany (5) · Netherlands (4) · Slovenia (4) · Spain (4) · China (3) · Serbia (3) · Austria (2) · Brazil (2) · France (2) · Hungary (2) · Italy (2) · Poland (2) · Taiwan (2)
Ida Jovanovic, Prof,MD,PhD (2) · Michael Burch, Prof,MD,PhD (2) · A. G. Kfoury, MD (1) · Amit Patel, MD (1) · Andreas M Zeiher (1) · Andrew Kao, MD (1) · Anthony Mathur (1) · Anthony Mathur, MD FRCP FESC (1) · Antonio Torrers, MD, PhD (1) · Barry Greenberg, MD (1) · Barry London, MD (1) · Bojan Vrtovec, MD, PhD (1) · Brian Halliday, MBChB PhD (1)
PMID 25142002, PMID 36718638, PMID 38979608, PMID 18553028, PMID 19327618, PMID 21440864, PMID 21645332, PMID 21709064, PMID 22651868, PMID 22936827, PMID 23065358, PMID 23362308, PMID 24030420, PMID 24065463, PMID 25097199, PMID 25354998, PMID 25459687, PMID 25650370, PMID 26082085, PMID 26555602, PMID 28636901, PMID 28974553, PMID 29380563, PMID 29654125, PMID 29880546, PMID 30005555, PMID 31438858, PMID 31616309, PMID 34048282, PMID 36114020, PMID 36515663, PMID 37010012, PMID 37190883, PMID 40145630, PMID 41217321
2015 (2), 2019 (2), 2004 (1), 2009 (1), 2018 (1), 2025 (1), K23HL071562 (1), R01HL080152 (1), R01HL110737 (1)